The loss of E-cadherin has been demonstrated as a marker of EMT and seems to correlate with dedifferentiation, local invasiveness, and metastasis formation of prostate cancer cells [26], [30], [31]. The gene discussed is CDH1; the disease is prostate carcinoma.